[External quality assurance of inpatient treatment in schizophrenia. results of a multicenter study].
Due to legal regulations, external quality assurance is mandatory in Germany. Supported by the German Health Ministry (BMG), we present the results of a multicenter study in four hospitals with different structures on 1042 inpatients with the tracer diagnosis of schizophrenia (ICD 10). We defined disease-specific indicators of structure, process, and outcome quality, developed an assessment instrument, and implemented a feedback system for quality comparison. The resulting quality profiles are useful as a starting point for internal quality management.
Janssen
B
B
Psychiatrische Klinik der Heinrich-Heine-Universität, Rheinische Kliniken, Düsseldorf.
Burgmann
C
C
Habel
U
U
Held
T
T
Hoff
P
P
Jänner
M
M
Mecklenburg
H
H
Prüter
C
C
Ruth
A
A
Sass
H
H
Schneider
F
F
Gaebel
W
W
D000208:Acute Disease; D014150:Antipsychotic Agents / Q000008:administration & dosage; D005260:Female; D005858:Germany; D006785:Hospitals, University / Q000592:standards* / Q000706:statistics & numerical data; D006801:Humans; D007297:Inpatients / Q000706:statistics & numerical data*; D007902:Length of Stay; D008297:Male; D010043:Outcome and Process Assessment, Health Care / Q000379:methods*; D017060:Patient Satisfaction; D019984:Quality Indicators, Health Care; D012008:Recurrence; D012189:Retrospective Studies; D012559:Schizophrenia / Q000628:therapy*; D017749:Total Quality Management / Q000379:methods
D014150:Antipsychotic Agents